Get access

Applying principles of formulary management to blood banking

Authors

  • Nancy L. Fagan,

    Corresponding author
    1. University of Findlay, Findlay, Ohio
    2. Alegent Creighton Health Creighton University Medical Center, Omaha, Nebraska
    • Creighton University, Omaha, Nebraska
    Search for more papers by this author
  • Patrick M. Malone,

    1. Creighton University, Omaha, Nebraska
    2. University of Findlay, Findlay, Ohio
    3. Alegent Creighton Health Creighton University Medical Center, Omaha, Nebraska
    Search for more papers by this author
  • Richard J. Baltaro,

    1. Creighton University, Omaha, Nebraska
    2. University of Findlay, Findlay, Ohio
    3. Alegent Creighton Health Creighton University Medical Center, Omaha, Nebraska
    Search for more papers by this author
  • Mark A. Malesker

    1. Creighton University, Omaha, Nebraska
    2. University of Findlay, Findlay, Ohio
    3. Alegent Creighton Health Creighton University Medical Center, Omaha, Nebraska
    Search for more papers by this author

Address reprint requests to: Nancy L. Fagan, PharmD, Department of Pharmacy Practice, Creighton University, 2500 California Plaza, Omaha, NE 68178; e-mail: nfagan@creighton.edu.

Abstract

The pharmacy and therapeutics (P&T) committee or its equivalent has been a long-standing committee of the medical staff in almost every institution. The P&T committee is typically defined as the body that recommends policy to the medical staff and the administration of the organization on matters related to the safe and therapeutic use of medications as well as other matters relating to medication use. The Food and Drug Administration definition of a drug includes blood and blood components, and the American Society of Health-System Pharmacists guidelines suggest including blood derivatives in their definition of a drug. Clinicians and other health care providers have needed to become more familiar with blood and blood component therapy as more prescription blood products have become available. As such, the P&T committee could work collaboratively with blood bank personnel, who are experts in this area, to help ensure that blood derivative products undergo the same evidence-based formulary review process as other medications.

Ancillary